Navigation Links
FASEB announces 2014 Science Research Conference: 2nd International Conference on Retinoids
Date:1/22/2014

Bethesda, MD This 2014 Science Research Conference focuses on how retinoids are critical for many physiological and pathological processes, and how they can be developed into drugs to combat a broad array of diseases such as cancers, and neurological, dermatological, metabolic and immune diseases. This meeting also incorporates the "2nd International Retinoid Meeting", and expands the attendance from all the international scientific communities, including those in North America, Europe and Asia.

The meeting will address questions about retinoids in biology, chemistry and diseases, and particularly will emphasize issues related to clinical application and global health/nutrition. This conference will begin with a Round Table panel, followed by talks presented by highly regarded international scientists, constituting 8 symposia on fundamental problems of Retinoids (metabolism, enzymology and signaling), cutting edge clinical relevance (cancers, immunity, neurological and metabolic diseases), and new drug development (chemical biology of Retinoids).

The conference will conclude with a Poster Award section and a Meet the Expert section to foster networking among juniors/seniors, domestic/international, and academic/clinical/industrial investigators. Attendees are from academia, clinical practice and industry, and represent a wide range of specialties including, but not limited to, biochemistry, cell biology, structural biology, genetics, physiology, nutrition, medicine, and therapeutics. This meeting is the major international meeting on Retinoids held in North America. By incorporating attendees of the International Retinoid Meeting, this conference also has the biggest international representation in the field.


'/>"/>

Contact: Robin Crawford
301-634-7010
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1

Related biology news :

1. FASEB announces SRC: Molecular Mechanisms of Intestinal Lipid Transport & Metabolism
2. FASEB announces 2014 SRC: Protein Phosphorylation, Cellular Plasticity & Signaling Rewiring
3. FASEB announces 2014 SRC: Protein Interactions, Structures, Technologies & Networks
4. FASEB announces 2014 Science Research Conference: Biology & Pathobiology of Krueppel-Like Factors
5. FASEB announces BioArt image and video competition winners
6. MARC travel awards announced for the July 2013 FASEB Science Research Conferences
7. MARC travel awards announced for the June 2013 FASEB science research conferences
8. New FASEB analysis documents impact of budget cuts on biomedical research
9. FASEB MARC Travel Awards announced for the 2013 American College of Sports Medicine Northwest Chapter Meeting
10. FASEB joins President Obama in urging Congress to sustain investments in research and innovation
11. FASEB SRC announces conference registration open for: Melatonin Biology: Actions & Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... Jan. 24, 2017 Biopharm Reports has ... laboratory use of nuclear magnetic resonance spectroscopy (NMR). ... and profiled current practices, developments, trends and end-user ... as growth and opportunities. These areas include growth ... instruments, needs and innovation requirements, hyphenated NMR techniques, ...
(Date:1/23/2017)... 2017  The latest mobile market research from Acuity ... dramatically. The quarterly average price of a biometric smartphone ... Q4 2016.  There are now 120 sub-$150 models on ... from just 28 a year ago at an average ... Maxine Most , Acuity Market Intelligence Principal, "Biometric Smartphones ...
(Date:1/19/2017)... and PUNE, India , January 19, 2017 ... "Global Biometric Sensor Market, Opportunities and Forecast, 2014 - 2022," the global ... a CAGR of 9.6% from 2016 to 2022. In 2015, Asia-Pacific ... high-level security for both public and private sectors. ... ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... , Feb. 16, 2017  Windtree Therapeutics, Inc. ... focusing on developing aerosolized KL4 surfactant therapies for ... preclinical influenza study showed that aerosolized KL4 surfactant ... a well-established preclinical animal model. The Company believes ... body of evidence that supports the role of ...
(Date:2/15/2017)... ... February 15, 2017 , ... Executive search firm, Slone ... with GenePeeks. Matt is a veteran life sciences and molecular diagnostics executive ... focused on identifying inherited disease risk in future generations. In his new role, ...
(Date:2/15/2017)... Inc. (Vanda) (NASDAQ: VNDA), today announced financial and ... year ended December 31, 2016. "2016 ... continued to demonstrate strong growth in our commercial ... Mihael H. Polymeropoulos, M.D., Vanda,s President and CEO. ... milestones underscores Vanda,s commitment to bringing important new ...
(Date:2/15/2017)... ... 2017 , ... Diameter Health (Diameter) and Lantana ... in the hands of Lantana analysts. The high-performance platform of Diameter combined with ... entities – all those mining value from clinical data – to get the ...
Breaking Biology Technology: